Cohort Study: Recurrence and mortality risk of Merkel cell carcinoma by cancer stage and time from diagnosis.

Recurrence and Mortality Risk of Merkel Cell Carcinoma by Cancer Stage and Time From Diagnosis – JAMA Dermatology (link to abstract – $ for full-text)

Author Interview: Recurrence and Mortality Risk of Merkel Cell Carcinoma by Cancer Stage and Time From Diagnosis

News Release: Patients with rare skin cancer, Merkel cell carcinoma, face 40% recurrence rate – University of Washington School of Medicine

Commentary: #VisualAbstract: Stage-specific and time-specific recurrence data can help determine need for surveillance in Merkel cell carcinoma patients – Physician’s Weekly/2 Minute Medicine

Commentary on Twitter

In this cohort study, Merkel cell carcinoma (MCC) recurrence rate was 40%, more than 90% of MCC recurrences arose within 3 years. https://t.co/46rDnVtyHh

— JAMA Dermatology (@JAMADerm) February 23, 2022